Webinar on New directions for how we treat our patients
Bonalive
24.02.2021.
Summary:
- S53P4 bioactive glass enables one-stage surgery in chronic osteomyelitis treatment
- S53P4 bioactive glass is a potent biomaterial in chronic osteomyelitis treatment to encounter the antibiotic resistance problem.
- One-stage treatment with S53P4 bioactive glass is highly clinical and cost-effective compared to traditional two-stage surgery with antibiotic-loaded PMMA beads.
- S53P4 bioactive glass is not a “get-out-of-jail-card” for bad debridement!
- Technical note: always keep cortical windows long and narrow, broad windows increase risk for iatrogenic fracture.